These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32544081)

  • 1. The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study.
    Mo J; Chen Z; Xu J; Wang A; Meng X; Zhao X; Li H; Wu S; Wang Y
    Aging (Albany NY); 2020 Jun; 12(12):11990-12001. PubMed ID: 32544081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.
    Dai W; Zhang Z; Zhao S
    Lipids Health Dis; 2018 Dec; 17(1):273. PubMed ID: 30509306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study.
    Penson PE; Long DL; Howard G; Toth PP; Muntner P; Howard VJ; Safford MM; Jones SR; Martin SS; Mazidi M; Catapano AL; Banach M
    Eur Heart J; 2018 Oct; 39(40):3641-3653. PubMed ID: 30165636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
    Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity C-reactive protein and low-density lipoprotein cholesterol association with incident of cardiovascular events: Isfahan cohort study.
    Nafari A; Mohammadifard N; Haghighatdoost F; Nasirian S; Najafian J; Sadeghi M; Roohafza H; Sarrafzadegan N
    BMC Cardiovasc Disord; 2022 May; 22(1):241. PubMed ID: 35614388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.
    Small AM; Pournamdari A; Melloni GEM; Scirica BM; Bhatt DL; Raz I; Braunwald E; Giugliano RP; Sabatine MS; Peloso GM; Marston NA; Natarajan P
    JAMA Cardiol; 2024 Apr; 9(4):385-391. PubMed ID: 38353970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event.
    Munkhaugen J; Otterstad JE; Dammen T; Gjertsen E; Moum T; Husebye E; Gullestad L
    Eur J Prev Cardiol; 2018 Jun; 25(9):923-931. PubMed ID: 29635941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
    Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA.
    Kitagawa K; Hosomi N; Nagai Y; Kagimura T; Ohtsuki T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Nakamura M; Matsumoto M;
    J Atheroscler Thromb; 2019 May; 26(5):432-441. PubMed ID: 30318492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
    Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of individual and integrated cumulative burden of blood pressure, glucose, low-density lipoprotein cholesterol, and C-reactive protein on cardiovascular risk.
    Chen Z; Mo J; Xu J; Wang A; Dai L; Cheng A; Yalkun G; Meng X; Zhao X; Li H; Wu S; Wang Y
    Eur J Prev Cardiol; 2022 Feb; 29(1):127-135. PubMed ID: 33624037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels.
    Pischon T; Möhlig M; Hoffmann K; Spranger J; Weikert C; Willich SN; Pfeiffer AF; Boeing H
    Eur J Epidemiol; 2007; 22(7):429-38. PubMed ID: 17557140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Sensitivity C-Reactive Protein Combined with Low-Density Lipoprotein Cholesterol as the Targets of Statin Therapy in Patients with Acute Coronary Syndrome.
    Fang M; Qian Q; Zhao Z; Zhu L; Su J; Li X
    Int Heart J; 2018 Mar; 59(2):300-306. PubMed ID: 29479010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
    Razzouk L; Muntner P; Bansilal S; Kini AS; Aneja A; Mozes J; Ivan O; Jakkula M; Sharma S; Farkouh ME
    Am Heart J; 2009 Aug; 158(2):277-83. PubMed ID: 19619706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
    Everett BM; Kurth T; Buring JE; Ridker PM
    J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Density Lipoprotein Cholesterol Concentrations and Association of High-Sensitivity C-Reactive Protein Concentrations With Incident Coronary Heart Disease in the Multi-Ethnic Study of Atherosclerosis.
    Lin GM; Liu K; Colangelo LA; Lakoski SG; Tracy RP; Greenland P
    Am J Epidemiol; 2016 Jan; 183(1):46-52. PubMed ID: 26597828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.